Empe Diagnostics

Description: EMPE Diagnostics develops mfloDx® tech for rapid TB & drug-resistance detection in <3hrs, expanding to STDs. Customizable DNA/RNA platform.

Country: Sweden

Based in: Solna

Founded: 2015

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Health Diagnostics', 'Medical Device', 'Pharmaceutical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.